Report 2018
Rethink Tomorrow
Report 2018

GRI Content Index 2018

Since 2002, Novozymes has relied on the GRI framework to guide its integrated reporting. We have followed the developments in the GRI Standards (previously known as GRI Guidelines) over the years and use them as a yardstick to measure our sustainability performance.

 

Reporting specifications

Novozymes refers to GRI Standard 101: Foundation 2016 to inspire its materiality assessment process. Our material issues have been identified through a robust assessment process and mapped with relevant GRI Categories and Disclosures.

 

We refer to GRI 102: General Standard Disclosures 2016 to provide information on organizational profile, strategy, ethics and integrity, governance, stakeholder engagement and reporting practices. This information is reported throughout The Novozymes Report 2018 under relevant report sections.

The GRI 103: Management Approach 2016 guides our reporting on the management approach to material issues. Our disclosure on material issues is contained in the Accounts and performance section of The Novozymes Report 2018. The disclosure on management approach includes information on four aspects:

 

  1. Explanation of material topic and its boundary.
  2. Significance of material topic to Novozymes.
  3. Management approach, which describes how we manage the issue(s). This may include our strategy, policies, positions, commitments and targets, as well as any specific programs and initiatives in the area.
  4. Monitoring and performance, which describes how we evaluate our management approach and our performance in the area.

 

Furthermore, we have reported topic-specific disclosures for each of the material issues identified under Economic, Environmental and Social categories by referring to the GRI 200 Economic Standard, GRI 300 Environmental Standard and GRI 400 Social Standard respectively.

 

The GRI Index provided here serves as a guide to where you can find more detailed information on general and topic-specific information reported throughout The Novozymes Report 2018. 

 

The material issues have been mapped against their relevant GRI Categories and Disclosures to link Novozymes’ material issues to the nomenclature used by GRI.

Material Issues GRI Category (ies) Disclosure
Innovation Economic GRI 201: Economic Performance; GRI 203: Significant Indirect Economic Impact
Profitable growth Economic GRI 201: Economic Performance
Partnerships & customer engagement Economic and Social GRI 201: Economic Performance; GRI 416: Customer Health and Safety
Compliance Economic and Social GRI 307: Environmental Compliance; GRI 419: Socioeconomic Compliance
Climate change & energy Environmental GRI 305: Emissions; GRI 302: Energy
Business ethics General disclosure and Economic GRI 102-16 to 102-17: Ethics and Integrity; GRI 205: Anti-Corruption; GRI 206: Anti-Competitive Behavior
Corporate governance General disclosure and Economic GRI 102-18 to 102-39: Governance; GRI 405: Diversity and Equal Opportunity
Water Environmental GRI 303: Water and Effluents
Product stewardship Social GRI 416: Customer Health and Safety; GRI 417: Marketing and Labeling
Solid capital structure Economic GRI 201: Economic Performance
Trade policies Economic GRI 201-1: Direct Economic Value Generated and Distributed
Bioethics & biodiversity Environmental -
Occupational health & safety Social GRI 403: Occupational Health & Safety
Community engagement & social investment Economic and Social GRI 413: Local Communities; GRI 203: Significant Indirect Economic Impact
Responsible sourcing Environmental and Social GRI 308: Supplier Environmental Assessment; GRI 414: Supplier Social Assessment
Labor practices & human rights Social GRI 401: Employment; GRI 402: Labor Management Relations; GRI 404: Training and Education; GRI
405: Diversity and Equal Opportunity; GRI 407: Freedom of Association and Collective Bargaining; GRI 408: Child Labor; GRI 409: Forced or Compulsory Labor; GRI 414: Supplier Social Assessment; GRI 412: Human Rights Assessment
Waste Environmental GRI 306: Effluents and Waste
Data security Economic and Social GRI 102-29 to 30: Governance
Tax Economic GRI 201: Economic Performance
Animal welfare Environmental GRI 307: Environmental Compliance
Deforestation & land use change Environmental -
GRI DISCLOSURE REFERENCES AND COMMENTS REPORTING EXTENT
102-1 Name of the organization About the report in The Novozymes Report 2018 Full
102-2 Activities, brands, products and/or services This is Novozymes in The Novozymes Report 2018 Full
2018 in brief in The Novozymes Report 2018
Business model in The Novozymes Report 2018
102-3 Location of organization's headquarters Contact us on Novozymes.com Full
Note 6.8 Group companies in The Novozymes Report 2018
102-4 Locations of operations Contact us on Novozymes.com Full
Note 6.8 Group companies in The Novozymes Report 2018
Site data in The Novozymes Report 2018
102-5 Nature of ownership and legal form The Novozymes stock in The Novozymes Report 2018 Full
Corporate governance on Novozymes.com
102-6 Markets served This is Novozymes in The Novozymes Report 2018 Full
2018 in brief in The Novozymes Report 2018
102-7 Scale of the organization Note 2.1 Segment in The Novozymes Report 2018 Full
Note 2.2 Revenue
Note 2.3 Employees
Balance sheet and financial position
Note 6.8 Group companies in The Novozymes Report 2018
Site data in The Novozymes Report 2018
102-8 Employee information Novozymes does not disclose proprietary information on total workforce by employment contract Partial
Novozymes reports externally on site data, including number of employees, gender distribution, employee turnover, age, seniority and rate of absence
Note 2.3 Employees in The Novozymes Report 2018
Note 8.1 Labor practices & human rights in The Novozymes Report 2018
Site data in The Novozymes Report 2018
102-9 Describe the organization's supply chain Novozymes does not report this indicator publicly as this is proprietary information Not reported
102-10 Significant changes during the reporting period regarding size, structure, ownership or supply chain 2018 in brief in The Novozymes Report 2018 Partial
Materiality in Note 1 Basis of reporting in The Novozymes Report 2018
102-11 Precautionary principle or approach CEO statement of continued commitment: Innovating for a sustainable tomorrow in the Sustainability section of The Novozymes Report 2018 Full
Risk management in The Novozymes Report 2018
Note 7.7 Product stewardship in The Novozymes Report 2018
102-12 External initiatives Progress on the Ten Principles in the Sustainability section of The Novozymes Report 2018 Full
Action through industry and global organizations in the Sustainability section of The Novozymes Report 2018
102-13 Memberships of associations Action through industry and global organizations in the Sustainability section of The Novozymes Report 2018 Full
Policy advocacy and government partnerships in the Sustainability section of The Novozymes Report 2018
Better together on Novozymes.com
GRI DISCLOSURE REFERENCES AND COMMENTS REPORTING EXTENT
102-18 Governance structure Corporate governance in The Novozymes Report 2018 Full
Business model in The Novozymes Report 2018
Management & Ownership on Novozymes.com
102-19 Delegating authority The target-setting process at Novozymes ensures top-down approach for delegating authority for economic, environmental and social topics Full
Business model in The Novozymes Report 2018
Sustainability governance on Novozymes.com
Rules of procedure for the Board of Directors at investors.novozymes.com
102-20 Executive-level responsibility for economic, environmental and social topics Sustainability governance on Novozymes.com Full
Business model in The Novozymes Report 2018
Corporate governance in The Novozymes Report 2018
102-21 Consulting stakeholders on economic, environmental and social topics Sustainability governance on Novozymes.com Full
Driving action with our stakeholders in the Sustainability section of The Novozymes Report 2018
Materiality in Note 1 Basis of reporting in The Novozymes Report 2018
102-22 Composition of the highest governance body and its committees Corporate governance in The Novozymes Report 2018 Full
Executive Leadership Team in The Novozymes Report 2018
102-23 Chair of the highest governing body Board of Directors in The Novozymes Report 2018 Full
Executive Leadership Team in The Novozymes Report 2018
Management & Ownership on Novozymes.com
102-24 Nominating and selecting the highest governance body Rules of procedure for the Board of Directors at investors.novozymes.com Full
Board of Directors in The Novozymes Report 2018
102-25 Conflict of interest Not reported
102-26 Role of highest governance body in setting purpose, values and strategy Business model in The Novozymes Report 2018 Full
Sustainability governance on Novozymes.com
Corporate governance on Novozymes.com
102-27 Collective knowledge of highest governance body Sustainability governance on Novozymes.com Partial
Charter of the Audit Committee at investors.novozymes.com
102-28 Evaluating the highest governance body's performance Corporate governance in The Novozymes Report 2018 Full
Charter of the Audit Committee at investors.novozymes.com
102-29 Identifying and managing economic, environmental and social topics and their impacts, risks and opportunities Risk management in The Novozymes Report 2018 Full
Materiality in Note 1 Basis of reporting in The Novozymes Report 2018
102-30 Effectiveness of risk management processes Risk management in The Novozymes Report 2018 Full
Sustainability governance on Novozymes.com
102-31 Review of economic, environmental and social topics Risk management in The Novozymes Report 2018 Full
Materiality in Note 1 Basis of reporting in The Novozymes Report 2018
102-32 Highest governance body's role in sustainability reporting The Board of Directors and the Executive Leadership Team review and approve our integrated annual report Full
Charter of the Audit Committee at investors.novozymes.com
102-33 Communicating critical concerns Risk management in The Novozymes Report 2018 Full
Corporate governance in The Novozymes Report 2018
Note 8.3 Business ethics in The Novozymes Report 2018
102-34 Nature and total number of  critical concerns Note 8.3 Business ethics in The Novozymes Report 2018 Partial
102-35 Remuneration policies Guidelines for the compensation of the Board of Directors and Executive Leadership Team at Novozymes.com Full
Remuneration report in The Novozymes Report 2018
102-36 Process for determining remuneration Guidelines for the compensation of the Board of Directors and Executive Leadership Team at investors.novozymes.com Full
102-37 Stakeholders' involvement in remuneration Shareholders' meetings at investors.novozymes.com Partial
Guidelines for the compensation of the Board of Directors and Executive Leadership Team at investors.novozymes.com
102-38 Annual total compensation ratio Remuneration report in The Novozymes Report 2018 Partial
102-39 Percentage increase in annual total compensation ratio Novozymes does not report on this indicator Not reported
GRI disclosure References and comments Reporting extent
102-40 List of stakeholder groups Better together on Novozymes.com Full
Engagement in the Sustainability section of The Novozymes Report 2018
102-41 Collective bargaining agreements Novozymes does not report publicly on this information Not reported
Novozymes supports employees' rights to join associations and bargain collectively, but we do not register employees' memberships of unions, since this is illegal in several of the countries in which we operate
102-42 Identifying and selecting stakeholders Stakeholder engagement occurs across various functions and departments of Novozymes. We do not publicly disclose our basis for identifying and selecting stakeholders to engage with Partial
Communication Policy in Positions & Policies on Novozymes.com
Engagement in the Sustainability section of The Novozymes Report 2018
Materiality in Note 1 Basis of reporting in The Novozymes Report 2018
102-43 Approach to stakeholder engagement Materiality in Note 1 Basis of reporting in The Novozymes Report 2018 for information specific to stakeholder engagement in the materiality assessment process Partial
With the exception of stakeholder engagement in the materiality assessment process, we do not report frequency of engagement by type and stakeholder group as this is a continuous process
Engagement in the Sustainability section of The Novozymes Report 2018
Communication Policy in Positions & Policies on Novozymes.com
102-44 Key topics and concerns raised Materiality in Note 1 Basis of reporting in The Novozymes Report 2018 Partial
Engagement in the Sustainability section of The Novozymes Report 2018
GRI disclosure References and comments Reporting extent
102-45 Entities included in the consolidated financial statements Note 1 Basis of reporting in The Novozymes Report 2018 Full
Note 6.8 Group companies in The Novozymes Report 2018
102-46 Defining report content and topic boundaries Note 1 Basis of reporting in The Novozymes Report 2018 Full
102-47 List of material topics Materiality in Note 1 Basis of reporting in The Novozymes Report 2018 Full
Materiality and value chain assessment in the Sustainability section of The Novozymes Report 2018
Mapping material issues to GRI in Novozymes' Reporting on the GRI
102-48 Restatements of information Note 1 Basis of reporting in The Novozymes Report 2018 Full
102-49 Changes in reporting Note 1 Basis of reporting in The Novozymes Report 2018 Full
Materiality and value chain assessment in the Sustainability section of The Novozymes Report 2018
102-50 Reporting period Note 1 Basis of reporting in The Novozymes Report 2018 Full
About the report in The Novozymes Report 2018
102-51 Date of most recent report January 24, 2019 Full
102-52 Reporting cycle Novozymes' reporting cycle is annual Full
Note 1 Basis of reporting in The Novozymes Report 2018
102-53 Contact point for questions regarding the report About the report in The Novozymes Report 2018 Full
102-54 Claims of reporting in accordance with the GRI standards Approach to the GRI in the Sustainability section of The Novozymes Report 2018 Full
102-55 GRI content index Novozymes' Reporting on the GRI Full
102-56 External assurance Independent assurance statement on Novozymes' 2018 sustainability reporting and adherence to the AA1000 Accountability principles in The Novozymes Report 2018 Full
Independent auditor's report in The Novozymes Report 2018
GRI disclosure References and comments Reporting extent
GRI 201: Economic Performance
103 Management approach disclosures Strategy in The Novozymes Report 2018 Full
Letter from the Board of Directors: We have an obligation in The Novozymes Report 2018
Letter from the CEO: Building sustainable growth during times of rapid change in The Novozymes Report 2018
201-1 Direct economic value generated and distributed Novozymes does not disclose proprietary information on donations and community investments Partial
Sales and earnings in The Novozymes Report 2018
Note 2.3 Employees in The Novozymes Report 2018
Note 3.1 Intangible assets and impairment test of goodwill in The Novozymes Report 2018
The big picture in The Novozymes Report 2018
Business model in The Novozymes Report 2018
201-2 Financial implications and other risks and opportunities due to climate change Novozymes' disclosure on risks and opportunities related to climate change can be found in our response to the CDP Investor questionnaire at www.cdp.net Full
GRI 203: Indirect Economic Impacts
203-2 Significant indirect economic impacts Targets in The Novozymes Report 2018 Partial
The big picture in The Novozymes Report 2018
Business model in The Novozymes Report 2018
GRI 205: Anti-corruption
103 Management approach disclosures Note 8.3 Business ethics in The Novozymes Report 2018 Full
205-1 Operations assessed for risks related to corruption Note 8.3 Business ethics in The Novozymes Report 2018 Partial
Position paper on Business integrity in Positions & Policies on Novozymes.com
205-2 Communication and training about anti-corruption policies and procedures Note 8.3 Business ethics in The Novozymes Report 2018 Partial
Position paper on Business integrity in Positions & Policies on Novozymes.com
205-3 Confirmed incidents of corruption and actions taken Note 8.3 Business ethics in The Novozymes Report 2018 Partial
GRI 206: Anti-competitive Behavior
103 Management approach disclosures Note 8.3 Business ethics in The Novozymes Report 2018 Full
206-1 Legal actions for anti-competitive behavior, anti-trust and monopoly practices Note 8.3 Business ethics in The Novozymes Report 2018 Full
GRI disclosure References and comments Reporting extent
GRI 302: Energy
103 Management approach disclosures Note 7.2 Energy in The Novozymes Report 2018 Full
302-1 Energy consumption within the organization Note 7.2 Energy in The Novozymes Report 2018 Full
302-4 Reduction in energy consumption Environmental data in The Novozymes Report 2018 Partial
Note 7.2 Energy in The Novozymes Report 2018
GRI 303: Water and Effluents 2018
103 Management approach disclosures Note 7.3 Water in The Novozymes Report 2018 Full
303-1 Interactions with water as a shared resource Novozymes reports water withdrawal by type (such as drinking water, industrial water and steam), but does not disclose withdrawal by source Partial
303-3 Water withdrawal Note 7.3 Water in The Novozymes Report 2018 Partial
303-4 Water discharge Note 7.3 Water in The Novozymes Report 2018 Partial
GRI 305: Emissions
103 Management approach disclosures Note 7.1 Climate change in The Novozymes Report 2018 Full
305-1 Direct (Scope 1) GHG emissions Note 7.1 Climate change in The Novozymes Report 2018 Full
Our disclosure on emissions adheres to Novozymes' accounting policies and follows an operational control approach
Novozymes’ disclosure on biogenic emissions can be found in our response to the CDP Investor questionnaire on www.cdp.net
305-2 Energy indirect (Scope 2) GHG emissions Note 7.1 Climate change in The Novozymes Report 2018 Full
Our disclosure on emissions adheres to Novozymes' accounting policies and follows an operational control approach
305-3 Other indirect (Scope 3) GHG emissions Note 7.1 Climate change in The Novozymes Report 2018 Partial
GRI 306: Effluents and Waste
103 Management approach disclosures Note 7.3 Water in The Novozymes Report 2018 Full
Note 7.4 Waste in The Novozymes Report 2018
306-1 Total water discharge by quality and destination Novozymes does not report on the quality of the water or the treatment methods, because different sites apply different treatment methods and measures based on local requirements Partial
Note 7.3 Water in The Novozymes Report 2018
306-2 Waste by type and disposal method Environmental performance in The Novozymes Report 2018 Full
Note 7.4 Waste in The Novozymes Report 2018
The waste disposal method is site specific and determined in line with local requirements
306-3 Significant spills There were no significant spills in 2018 Full
GRI 307: Environmental Compliance
103 Management approach disclosures Note 7.5 Environmental compliance, etc. in The Novozymes Report 2018 Full
307-1 Non-compliance with environmental laws and regulations Novozymes did not receive any  significant fines or nonmonetary sanctions related to noncompliance with environmental laws and regulations in 2018 Full
Environmental performance in The Novozymes Report 2018
Note 7.5 Environmental compliance, etc. in The Novozymes Report 2018
GRI 308: Supplier Environmental Assessment
103 Management approach disclosures Note 8.6 Responsible sourcing in The Novozymes Report 2018 Full
308-1 New suppliers that were screened using environmental criteria Note 8.6 Responsible sourcing in The Novozymes Report 2018 Partial
GRI disclosure References and comments Reporting extent
GRI 401: Employment
103 Management approach disclosures Note 8.1 Labor practices & human rights in The Novozymes Report 2018 Full
401-1 New employee hires and employee turnover Note 8.1 Labor practices & human rights and Note 2.3 Employees in The Novozymes Report 2018 Partial
Social and governance performance in The Novozymes Report 2018
Site data in The Novozymes Report 2018
401-2 Benefits provided to full-time employees that are not provided to temporary or part-time employees Employee benefits, including life insurance, healthcare, disability/invalidity coverage, maternity/paternity leave, retirement provision and others are provided to full-time employees of Novozymes as a minimum, as required by law. Temporary and part-time employees (including interns) are entitled to a number of employee benefits, as per the national regulations and industry standards of the regions in which we operate Full
GRI 403: Occupational Health and Safety 2018
103 Management approach disclosures Note 8.2 Occupational health & safety in The Novozymes Report 2018 Full
403-1 Occupational health and safety management system Note 8.2 Occupational health & safety in The Novozymes Report 2018 Full
403-2 Hazard identification, risk assessment, and incident investigation Note 8.2 Occupational health & safety in The Novozymes Report 2018 Partial
403-3 Occupational health services Note 8.2 Occupational health & safety in The Novozymes Report 2018 Partial
403-7 Prevention and mitigation of occupational health and safety impacts directly linked by business relationships Note 8.2 Occupational health & safety in The Novozymes Report 2018 Partial
403-9 Work-related injuries Note 8.2 Occupational health & safety in The Novozymes Report 2018 Partial
Site data in the Novozymes Report 2018
403-10 Work-related ill health Note 8.2 Occupational health & safety in The Novozymes Report 2018 Partial
Site data in The Novozymes Report 2018
GRI 404: Training and Education
103 Management approach disclosures Note 8.1 Labor practices & human rights in The Novozymes Report 2018 Full
404-2 Programs for upgrading employee skills and transition assistance programs Targets: ENABLE in The Novozymes Report 2018 Partial
Note 8.1 Labor practices & human rights in The Novozymes Report 2018
GRI 405: Diversity and Equal Opportunity
103 Management approach disclosures Note 8.1 Labor practices & human rights in The Novozymes Report 2018 Full
405-1 Diversity of governance bodies and employees Novozymes reports on percentage employees by job category, but not on minority groups because registration of ethnic origin is illegal in many of the regions in which we operate Partial
Competency profile of the Board of Directors at investors.novozymes.com
Note 2.3 Employees in The Novozymes Report 2018
Target: ENABLE in The Novozymes Report 2018
Corporate governance in The Novozymes Report 2018
GRI 407: Freedom of Association and Collective Bargaining
407-1 Operations and suppliers in which the right to freedom of association and collective bargaining may be at risk Novozymes recognizes the right to organize and negotiate. This has led to various arrangements in countries where this right is not recognized in local legislation. Novozymes supports employees’ rights to join associations and bargain collectively, but we do not register employees’ memberships of unions, since this is illegal in several of the countries in which we operate Partial
Position paper on Human rights and labor standards on Novozymes.com
Note 8.1 Labor practices & human rights in The Novozymes Report 2018
GRI 408: Child Labor
103 Management approach disclosures Note 8.1 Labor practices & human rights in The Novozymes Report 2018 Full
408-1 Operations and suppliers identified at significant risk for incidents of child labor Position paper on Human rights and labor standards on Novozymes.com Partial
Note 8.1 Labor practices & human rights in The Novozymes Report 2018
GRI 409: Forced and Compulsory Labor
103 Management approach disclosures Note 8.1 Labor practices & human rights in The Novozymes Report 2018 Full
409-1 Operations and suppliers identified at significant risk for incidents of forced or compulsory labor Position paper on Human rights and labor standards on Novozymes.com Partial
Note 8.1 Labor practices & human rights in The Novozymes Report 2018
GRI 412: Human Rights Assessments
103 Management approach disclosures Note 8.1 Labor practices & human rights in The Novozymes Report 2018 Full
412-1 Total number and percentage of operations that have been subject to human rights reviews or human rights impact assessments, by country. Note 8.1 Labor practices & human rights in The Novozymes Report 2018 Full
GRI 413: Local Communities
103 Management approach disclosures Note 8.4 Community engagement in The Novozymes Report 2018 Full
413-1 Operations with local community engagement, impact assessments and development programs We have programs focused on education and are implemented with local communities in regions of significant operations. Partial
Note 8.4 Community engagement in The Novozymes Report 2018
ESG integration on Novozymes.com
Strategic social investment in the Sustainability section of The Novozymes Report 2018
GRI 414: Supplier Social Assessment
103 Management approach disclosures Note 8.6 Responsible sourcing in The Novozymes Report 2018 Full
414-1 New suppliers that were screened using social criteria Note 8.6 Responsible sourcing in The Novozymes Report 2018 Partial
Position paper on responsible purchasing on Novozymes.com
GRI 416: Customer Health and Safety
103 Management approach disclosures Note 7.7 Product stewardship in The Novozymes Report 2018 Full
416-1 Assessment of health and safety impacts of products and services 100% of our significant product and service categories are assessed for health and safety impacts Full
Novozymes’ Quality and Product Safety Policy on Novozymes.com
Enzymes and safety on Novozymes.com
Safety material on Novozymes TV
GRI 417: Maketing and Labeling
103 Management approach disclosures Note 7.7 Product stewardship in The Novozymes Report 2018 Full
417-1 Requirements for product and service information and labeling 100% of our significant product and service categories are covered by and assessed for compliance with labeling and regulatory requirements Full
Regulatory compliance on Novozymes.com
Back to notes
Scroll to top